See more : MISUMI Group Inc. (MSUXF) Income Statement Analysis – Financial Results
Complete financial analysis of Biomerica, Inc. (BMRA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Biomerica, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Cintas Corp (CIT.DE) Income Statement Analysis – Financial Results
- Pelangio Exploration Inc. (PGXPF) Income Statement Analysis – Financial Results
- Jinxin Technology Holding Company American Depositary Shares (NAMI) Income Statement Analysis – Financial Results
- European Sustainable Growth Acquisition Corp. (EUSG) Income Statement Analysis – Financial Results
- Wi2Wi Corporation (ISEYF) Income Statement Analysis – Financial Results
Biomerica, Inc. (BMRA)
About Biomerica, Inc.
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.42M | 5.34M | 18.87M | 7.20M | 6.69M | 5.20M | 5.56M | 5.79M | 5.14M | 4.96M | 5.12M | 6.47M | 6.08M | 4.90M | 5.08M | 4.93M | 4.93M | 5.75M | 7.18M | 9.27M | 9.17M | 9.06M | 8.60M | 8.94M | 8.03M | 8.70M | 9.40M | 9.20M | 9.50M | 9.20M | 8.30M | 8.00M | 7.80M | 10.40M | 8.20M | 1.20M | 1.40M | 1.90M | 1.70M |
| Cost of Revenue | 4.80M | 4.89M | 15.89M | 6.70M | 4.91M | 3.91M | 3.81M | 3.77M | 3.62M | 3.42M | 3.45M | 4.05M | 3.78M | 3.37M | 3.51M | 2.96M | 2.79M | 3.50M | 4.78M | 6.19M | 6.25M | 6.16M | 6.06M | 6.13M | 5.40M | 5.10M | 5.30M | 5.20M | 5.10M | 4.80M | 4.30M | 4.80M | 4.80M | 6.70M | 4.00M | 800.00K | 1.00M | 800.00K | 1.20M |
| Gross Profit | 611.00K | 446.00K | 2.98M | 496.98K | 1.78M | 1.29M | 1.75M | 2.02M | 1.52M | 1.54M | 1.67M | 2.43M | 2.30M | 1.53M | 1.56M | 1.97M | 2.14M | 2.25M | 2.41M | 3.09M | 2.92M | 2.90M | 2.54M | 2.81M | 2.63M | 3.60M | 4.10M | 4.00M | 4.40M | 4.40M | 4.00M | 3.20M | 3.00M | 3.70M | 4.20M | 400.00K | 400.00K | 1.10M | 500.00K |
| Gross Profit Ratio | 11.28% | 8.35% | 15.78% | 6.90% | 26.62% | 24.84% | 31.53% | 34.91% | 29.65% | 31.07% | 32.60% | 37.51% | 37.78% | 31.14% | 30.75% | 39.92% | 43.35% | 39.07% | 33.48% | 33.27% | 31.81% | 31.99% | 29.49% | 31.43% | 32.75% | 41.38% | 43.62% | 43.48% | 46.32% | 47.83% | 48.19% | 40.00% | 38.46% | 35.58% | 51.22% | 33.33% | 28.57% | 57.89% | 29.41% |
| Research & Development | 1.49M | 1.58M | 1.81M | 2.41M | 1.91M | 1.68M | 1.40M | 1.13M | 780.33K | 733.64K | 589.87K | 459.09K | 347.13K | 420.57K | 455.17K | 278.31K | 259.09K | 256.10K | 239.00K | 274.29K | 273.98K | 262.84K | 159.76K | 322.12K | 898.12K | 500.00K | 600.00K | 300.00K | 300.00K | 300.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.61K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.22K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 5.49M | 6.09M | 5.70M | 4.61M | 2.27M | 2.03M | 1.84M | 1.85M | 1.57M | 1.48M | 1.53M | 1.45M | 1.45M | 1.24M | 1.47M | 1.44M | 1.37M | 1.47M | 2.26M | 3.05M | 2.96M | 2.85M | 2.84M | 3.17M | 5.70M | 3.10M | 3.10M | 2.90M | 3.10M | 3.30M | 3.40M | 3.00M | 3.60M | 4.80M | 3.70M | 1.20M | 1.90M | 2.30M | 2.40M |
| Other Expenses | 0.00 | 1.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.01K | 2.26K | 3.13K | 50.00 | 0.00 | 290.17K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 6.98M | 7.67M | 7.51M | 7.02M | 4.18M | 3.70M | 3.24M | 2.98M | 2.35M | 2.21M | 2.12M | 1.91M | 1.79M | 1.66M | 1.93M | 1.72M | 1.63M | 1.72M | 2.50M | 3.32M | 3.23M | 3.11M | 3.00M | 3.49M | 6.82M | 3.90M | 3.90M | 3.40M | 3.70M | 4.00M | 3.80M | 3.50M | 4.40M | 5.60M | 4.20M | 1.30M | 2.00M | 2.40M | 2.60M |
| Cost & Expenses | 11.78M | 12.56M | 23.41M | 13.72M | 9.10M | 7.61M | 7.05M | 6.75M | 5.97M | 5.63M | 5.57M | 5.96M | 5.58M | 5.03M | 5.44M | 4.69M | 4.42M | 5.23M | 7.28M | 9.51M | 9.48M | 9.27M | 9.06M | 9.62M | 12.22M | 9.00M | 9.20M | 8.60M | 8.80M | 8.80M | 8.10M | 8.30M | 9.20M | 12.30M | 8.20M | 2.10M | 3.00M | 3.20M | 3.80M |
| Interest Income | 431.00K | 133.00K | 26.64K | 66.86K | 71.19K | 44.01K | 47.76K | 46.35K | 24.12K | 21.91K | 17.18K | 10.71K | 8.35K | 7.37K | 14.71K | 29.87K | 33.55K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 26.64K | 367.00 | 9.00 | 47.00 | 37.00 | 282.00 | 167.00 | 0.00 | 142.00 | 302.00 | 1.59K | 5.83K | 12.32K | 27.52K | 49.54K | 35.05K | 0.00 | 0.00 | 0.00 | 0.00 | 40.37K | 0.00 | 0.00 | 0.00 | 0.00 | 100.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 374.00K | 351.00K | 594.82K | 375.86K | 398.63K | 162.91K | 186.60K | 219.22K | 232.42K | 253.28K | 207.03K | 216.71K | 180.12K | 147.81K | 114.01K | 88.65K | 65.83K | 56.74K | 122.05K | 159.32K | 144.16K | 116.55K | 192.42K | 208.99K | 222.33K | 300.00K | 200.00K | 200.00K | 300.00K | 400.00K | 400.00K | 500.00K | 800.00K | 800.00K | 500.00K | 100.00K | 100.00K | 100.00K | 200.00K |
| EBITDA | -5.99M | -6.74M | -3.94M | -7.06M | -2.27M | -2.21M | -1.25M | -689.34K | -563.57K | -393.15K | -219.25K | 741.48K | 795.16K | 313.09K | -218.12K | 383.36K | 1.72M | 537.49K | 24.96K | -75.45K | -171.98K | -93.34K | -273.00K | -408.86K | -3.97M | 0.00 | 400.00K | 800.00K | 1.00M | 800.00K | 600.00K | 200.00K | -600.00K | -1.10M | 800.00K | -800.00K | -1.50M | -1.20M | -1.90M |
| EBITDA Ratio | -110.67% | -128.71% | -20.73% | -84.45% | -28.88% | -42.42% | -22.42% | -11.90% | -10.96% | -7.92% | -4.28% | 11.45% | 11.27% | 6.39% | -4.65% | 7.42% | -11.66% | 9.35% | -0.29% | -1.20% | -2.74% | -1.80% | -2.80% | -5.84% | -50.86% | -3.45% | 2.13% | 7.61% | 10.53% | 8.70% | 7.23% | 1.25% | -8.97% | -10.58% | 9.76% | -75.00% | -178.57% | -57.89% | -105.88% |
| Operating Income | -6.37M | -7.22M | -4.53M | -6.52M | -2.40M | -2.41M | -1.48M | -954.63K | -826.95K | -670.60K | -446.59K | 514.01K | 505.00K | -132.26K | -364.52K | 247.66K | 509.49K | 520.79K | -97.09K | -234.76K | -316.14K | -209.88K | -465.42K | -683.58K | -4.19M | -300.00K | 200.00K | 600.00K | 700.00K | 400.00K | 200.00K | -300.00K | -1.40M | -1.90M | 300.00K | -900.00K | -1.60M | -1.30M | -2.10M |
| Operating Income Ratio | -117.58% | -135.29% | -24.03% | -90.60% | -35.90% | -46.39% | -26.63% | -16.48% | -16.09% | -13.51% | -8.72% | 7.94% | 8.30% | -2.70% | -7.18% | 5.02% | 10.34% | 9.06% | -1.35% | -2.53% | -3.45% | -2.32% | -5.41% | -7.65% | -52.16% | -3.45% | 2.13% | 6.52% | 7.37% | 4.35% | 2.41% | -3.75% | -17.95% | -18.27% | 3.66% | -75.00% | -114.29% | -68.42% | -123.53% |
| Total Other Income/Expenses | 431.00K | 134.00K | 26.64K | 66.50K | 71.18K | 43.97K | 47.73K | 46.07K | 30.97K | 24.16K | 20.17K | 10.46K | 108.45K | 291.71K | 20.07K | 19.52K | 1.13M | 4.99K | 785.00 | 215.24K | 18.91K | -11.77K | -99.19K | 103.21K | 301.56K | 300.00K | -200.00K | 100.00K | 0.00 | 0.00 | 100.00K | 100.00K | 100.00K | 900.00K | -300.00K | 100.00K | 1.00M | -100.00K | -100.00K |
| Income Before Tax | -5.94M | -7.09M | -4.51M | -6.46M | -2.33M | -2.37M | -1.43M | -908.56K | -795.99K | -646.43K | -426.42K | 524.46K | 613.45K | 159.45K | -344.46K | 267.18K | 1.64M | 525.78K | 155.37K | -19.53K | -297.23K | -221.65K | -564.61K | -576.49K | -3.89M | 0.00 | 400.00K | 700.00K | 0.00 | 0.00 | 300.00K | -200.00K | -1.30M | -1.00M | 0.00 | -800.00K | -600.00K | -1.40M | -2.20M |
| Income Before Tax Ratio | -109.62% | -132.78% | -23.88% | -89.68% | -34.84% | -45.55% | -25.77% | -15.69% | -15.49% | -13.03% | -8.33% | 8.10% | 10.09% | 3.25% | -6.79% | 5.41% | 33.35% | 9.15% | 2.16% | -0.21% | -3.24% | -2.45% | -6.57% | -6.45% | -48.40% | 0.00% | 4.26% | 7.61% | 0.00% | 0.00% | 3.61% | -2.50% | -16.67% | -9.62% | 0.00% | -66.67% | -42.86% | -73.68% | -129.41% |
| Income Tax Expense | 42.00K | 51.00K | 23.72K | 13.06K | 7.39K | 24.24K | 31.80K | 46.64K | 703.80K | -315.02K | -210.76K | -12.49K | 65.01K | 2.00K | -13.00K | -87.00K | -67.00K | 16.77K | 1.60K | 1.94K | 1.82K | 2.22K | 2.06K | 2.40K | 2.40K | -200.00K | 100.00K | 200.00K | 300.00K | 300.00K | 300.00K | 100.00K | -500.00K | 200.00K | 600.00K | 0.00 | -1.20M | 0.00 | -200.00K |
| Net Income | -5.98M | -7.14M | -4.53M | -6.47M | -2.34M | -2.39M | -1.47M | -908.56K | -1.50M | -331.41K | -215.66K | 536.96K | 548.44K | 157.45K | -331.46K | 354.18K | 1.71M | 536.88K | 230.27K | 162.26K | -223.20K | -223.87K | -420.74K | -2.67M | -3.89M | -100.00K | 100.00K | 400.00K | 400.00K | 100.00K | 0.00 | -400.00K | -900.00K | -1.20M | -600.00K | -900.00K | -400.00K | -1.30M | -1.90M |
| Net Income Ratio | -110.40% | -133.73% | -24.01% | -89.86% | -34.95% | -46.01% | -26.34% | -15.69% | -29.18% | -6.68% | -4.21% | 8.30% | 9.02% | 3.21% | -6.53% | 7.18% | 34.71% | 9.34% | 3.20% | 1.75% | -2.43% | -2.47% | -4.89% | -29.89% | -48.43% | -1.15% | 1.06% | 4.35% | 4.21% | 1.09% | 0.00% | -5.00% | -11.54% | -11.54% | -7.32% | -75.00% | -28.57% | -68.42% | -111.76% |
| EPS | -0.36 | -0.50 | -0.36 | -0.54 | -0.23 | -0.26 | -0.17 | -0.11 | -0.20 | -0.04 | -0.03 | 0.08 | 0.08 | 0.02 | -0.05 | 0.05 | 0.28 | 0.09 | 0.04 | 0.03 | -0.04 | -0.04 | -0.08 | -0.56 | -0.86 | -0.03 | 0.04 | 0.12 | 0.12 | 0.03 | 0.02 | -0.14 | -0.30 | -0.40 | -0.18 | -0.30 | -0.14 | -0.44 | -0.66 |
| EPS Diluted | -0.36 | -0.50 | -0.36 | -0.54 | -0.23 | -0.26 | -0.17 | -0.11 | -0.20 | -0.04 | -0.03 | 0.07 | 0.08 | 0.02 | -0.05 | 0.05 | 0.25 | 0.08 | 0.03 | 0.03 | -0.04 | -0.04 | -0.08 | -0.56 | -0.86 | -0.03 | 0.03 | 0.10 | 0.12 | 0.03 | 0.02 | -0.14 | -0.30 | -0.40 | -0.18 | -0.30 | -0.14 | -0.44 | -0.66 |
| Weighted Avg Shares Out | 16.82M | 14.15M | 12.67M | 11.93M | 10.17M | 9.21M | 8.57M | 8.26M | 7.50M | 7.55M | 7.19M | 7.02M | 6.89M | 6.67M | 6.65M | 6.62M | 6.13M | 5.93M | 5.76M | 5.75M | 5.74M | 5.30M | 5.10M | 4.81M | 4.54M | 4.00M | 4.00M | 3.86M | 3.59M | 3.33M | 3.33M | 2.86M | 3.00M | 3.00M | 3.33M | 3.00M | 2.86M | 2.95M | 2.88M |
| Weighted Avg Shares Out (Dil) | 16.82M | 14.15M | 12.67M | 11.93M | 10.17M | 9.21M | 8.57M | 8.33M | 7.63M | 7.55M | 7.37M | 7.45M | 7.11M | 6.70M | 6.65M | 7.01M | 6.98M | 6.51M | 6.22M | 6.62M | 5.74M | 5.30M | 5.10M | 4.81M | 4.54M | 4.00M | 4.00M | 3.87M | 3.59M | 3.33M | 3.33M | 2.86M | 3.00M | 3.00M | 3.33M | 3.00M | 2.86M | 2.95M | 2.88M |
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.60%
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.60%
The 7 Best Cheap Stocks Under $10 Right Now
Here are seven cheap stocks to buy in the second half of the year. They come with risk, but could offer head-turning reward potential, too.
Biomerica (NASDAQ:BMRA) Shares Gap Up to $11.31
Biomerica, Inc. (NASDAQ:BMRA) shares gapped up prior to trading on Friday . The stock had previously closed at $12.72, but opened at $11.31. Biomerica shares last traded at $11.00, with a volume of 7,743 shares changing hands. A number of...
Biomerica (NASDAQ:BMRA) Trading 20.5% Higher
Biomerica, Inc. (NASDAQ:BMRA)’s share price was up 20.5% during mid-day trading on Monday . The company traded as high as $6.31 and last traded at $7.30, approximately 6,342,171 shares traded hands during trading. An increase of 1,303% from the average...
$1.90 Million in Sales Expected for Biomerica, Inc. (NASDAQ:BMRA) This Quarter
Wall Street analysts predict that Biomerica, Inc. (NASDAQ:BMRA) will report sales of $1.90 million for the current fiscal quarter, Zacks reports. Two analysts have made estimates for Biomerica’s earnings, with the highest sales estimate coming in at $2.45 million and...
UPS AND DOWNS
NEW YORK (AP) —The following list shows the Nasdaq stocks that have gone up the most and down the most based on percent of change for 2019. No securities trading below 1000 shares are included. Net and percentage change are...
Company News for Apr 3, 2020
Companies In The News Are: NEPT, BMRA, LK, WBA
Un rápido pinchazo en tu dedo puede determinar si ya has tenido el coronavirus: así funcionan los test de anticuerpos
Un análisis de sangre rápido podría ayudarte a averiguar si has desarrollado anticuerpos para el nuevo coronavirus, lo que implica que ya lo has tenido.
The Coronavirus Effect: Pandemic Stocks and Sympathy Plays
Right now, that means you need to keep up with pandemic stocks and sympathy plays. How can you find opportunities? Read on!
Source: https://incomestatements.info
Category: Stock Reports